Search

Subject Muscles

21. Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?. Issue 4 (17th April 2014)

Authors:
Fogelman, David R.; Holmes, Holly; Mohammed, Khalil; Katz, Matthew H. G.; Prado, Carla M.; Lieffers, Jessica; Garg, Naveen; Varadhachary, Gauri R.; Shroff, Rachna; Overman, Michael J.; Garrett, Christopher; Wolff, Robert A.; Javle, Milind
Journal:
Journal of cachexia, sarcopenia and muscle
Issue:
Volume 5:Issue 4(2014)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. Anamorelin HCl (ONO‐7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia‐cachexia syndrome: preclinical profile. Issue 4 (30th September 2014)

Authors:
Pietra, Claudio; Takeda, Yasuhiro; Tazawa-Ogata, Naoko; Minami, Masashi; Yuanfeng, Xia; Duus, Elizabeth Manning; Northrup, Robert
Journal:
Journal of cachexia, sarcopenia and muscle
Issue:
Volume 5:Issue 4(2014)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin‐like growth factor‐1 axis signaling in patients with advanced heart failure. Issue 4 (7th August 2014)

Authors:
Khawaja, Tuba; Chokshi, Aalap; Ji, Ruiping; Kato, Tomoko S.; Xu, Katherine; Zizola, Cynthia; Wu, Christina; Forman, Daniel E.; Ota, Takeyoshi; Kennel, Peter; Takayama, Hiroo; Naka, Yoshifumi; George, Isaac; Mancini, Donna; Schulze, Christian P.
Journal:
Journal of cachexia, sarcopenia and muscle
Issue:
Volume 5:Issue 4(2014)
Page Start:
297
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗